UPLC-MS/MS Metabolomics Reveals Babao Dan's Mechanisms in MASH Treatment with Integrating Network Pharmacology and Molecular Docking.

Pharmaceuticals (Basel) · 2025 · PMC12388948 · PMID 40872503

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

The clinical research results of BBD are consistent with the preclinical research results, and all the experiments mentioned above showed a decreasing trend in AST and ALT after treatment.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.